Generic drug of the therapeutic class: Dermatology
Active ingredients: Benzoyl Peroxide
laboratory: Fabre Pierre Dermato
Gel for local application
45 g tube
Dosage ECLARAN 10 gel for local application 45 g tube
Hypersensitivity to peroxides or to any of the excipients of E claran 10.
Adverse effects Eclaran 10
The undesirable effects reported with ECLARAN are listed below by frequency category, according to the following convention:
Very common (? 1/10), common (? 1/100 to <1/10), not very common (? 1/1000 to 1/100), rare (? 1/10 000 to 1) / 1000), very rare (<1 / 10, 000) and undetermined frequency (can not be estimated on the basis of available data).
Skin and subcutaneous tissue disorders
Significant or prolonged irritant phenomena at the application site (šrythÃme, desquamation), despite the good observance of the precautions for use,
With contact dermatitis,
General disorders and administration site abnormalities
OedÃžme of the face.
Declaration of suspected undesirable effects
The declaration of undesirable effects suspected after authorization of the drug is important. It allows continuous monitoring of the beneficial / risk ratio of the drug. Healthcare professionals declare any suspected adverse effects via the national system of declaration: National Agency for the Safety of Medicines and Health Products (ANSM) and the Network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.